Page 32 - Share Market

Vodafone Idea share price soars 6% on Q2 results; key highlights inside

Vodafone Idea's shares climbed 6.31 per cent to log an intraday high of ₹10.10 per share on the NSE

Nomura lifts Lupin target price on US momentum, India growth recovery

However, on the bourses, Lupin shares were trading 0.70 per cent lower at ₹1,973.50 per share at 9:30 AM. In comparison, BSE Sensex was trading 0.23 per cent lower at 83,346.45 levels.

Top stocks to buy today: Analyst bets on Cummins India, Infosys; check why

Shrikant Chouhan, head of equity research at Kotak Securities, remains upbeat on Cummins India and Infosys shares today. Check out the key reasons here

Want dividends? Keep an eye on these 5 stocks today; check full list

Dividend stocks today, Nov 11, 2025: Here is the complete list of stocks to watch today for their interim payouts

Dividend stocks today: These 10 stocks to remain in focus; do you own any?

Dividend stocks: Among the companies, Nuvama Wealth Management tops the list with an interim dividend of ₹70 per share

Tata Motors demerger: CV shares entitlement, swap ratio, listing timeline

Once listed, the CV stock will debut under a separate ticker, allowing independent trading of the two Tata Motors companies

Pocket dividends! ONGC, Power Grid, 31 other stocks go ex-date next week

Here's the complete list of stocks that will remain in focus next week, following their dividend announcements, along with key details

Cummins India share hits all-time high as Q2 profit zooms 42% YoY; details

Cummins India remains cautiously optimistic about its growth outlook across domestic and international markets, supported by a diversified portfolio aligned with evolving emission norms.

Q2 premium, margin growth boost analysts' bullish outlook on LIC stock

Emkay Global Financial Services has retained its 'Add' rating on the insurance behemoth, while Motilal Oswal Financial Services (MOFSL) has maintained its 'Buy' recommendation

Zydus Life Q2: Solid beat on bottom line, analysts mixed on growth outlook

Zydus Life Q2 results review: Foreign brokerage Nomura said Zydus Life delivered results above estimates, led by a stronger-than-expected performance in India.

Q2FY26 results in line; Aurobindo Pharma could gain 25%, says Nuvama

According to Nuvama, Aurobindo's Q2FY26 revenue and Ebitda were ahead of consensus estimates by 2 per cent and 1 per cent, respectively, though PAT missed expectations by about 5 per cent

MFs near parity with FIIs as ownership gap hits record low: Prime Database

The share of FIIs declined further to a 13-year low of 16.71 per cent as on September 30, 2025 (down from 17.05 per cent on June 30, 2025), while MF holdings rose to an all-time high of 10.93 per cent

Suzlon Energy shares gain 2% on Q2 results; should you buy, sell, or hold?

Suzlon Energy reported a net profit of ₹1,278 crore in Q2FY26, a significant jump from ₹200 crore in the same period last year, boosted by a tax write-back of ₹718 crore

Motilal Oswal gives 'Buy' to Waaree Energies, calls it a sector bellwether

With operational cell/module capacity of 5.4 GW/16.1 GW in India, WEL, analysts believe, towers domestic competitors and enjoys a formidable India capacity market share of 21.6 per cent/13.3 per cent

Here's why Systematix Corporate Services shares rose 10% in trade on Nov 4

Systematix Corporate Services share price soared 9.96 per cent to log an intraday high of ₹176.32 per share on the NSE on Tuesday.

Why are Dynamatic Technologies shares buzzing in trade on Nov 4? Find here

At 2 PM, Dynamatic Technologies share price was trading 6.32 per cent higher at ₹8,567.90 per share. By comparison, BSE Sensex was trading 0.36 per cent lower at 83,674.53 levels.

Hitachi Energy shares soar 13% on Q2FY26 results; check key details inside

Hitachi Energy's net profit in Q2FY26 rose more than fivefold to ₹264 crore, compared to ₹52 crore in Q2FY25

3M India share price skyrockets 19.5% as Q2 profit zooms 43% YoY; details

3M India share price rallied on the back of a strong set of numbers reported in the September quarter of financial year 2026 (Q2FY26).

RITES share rises 3% on securing deal worth ₹373 cr from NIMHANS Bengaluru

RITES share price rose after the company announced that it has secured an order worth ₹372.68 crore from NIMHANS Bengaluru.

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

With larger generic companies facing growth challenges in the US in FY27E, Ajanta Pharma, analysts believe, offers a strong investment opportunity, driven by its branded market growth